ID: ALA455684

Max Phase: Preclinical

Molecular Formula: C14H12N2OS

Molecular Weight: 256.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCC(=O)N1c2ccccc2Sc2ccccc21

Standard InChI:  InChI=1S/C14H12N2OS/c15-9-14(17)16-10-5-1-3-7-12(10)18-13-8-4-2-6-11(13)16/h1-8H,9,15H2

Standard InChI Key:  IIQVHKINCMEVON-UHFFFAOYSA-N

Associated Targets(non-human)

Lanosterol 14-alpha demethylase 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 256.33Molecular Weight (Monoisotopic): 256.0670AlogP: 2.77#Rotatable Bonds: 1
Polar Surface Area: 46.33Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.96CX LogP: 2.02CX LogD: 1.36
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.85Np Likeness Score: -0.88

References

1. Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Alteköster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR..  (2007)  Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.,  51  (11): [PMID:17846131] [10.1128/aac.00311-07]

Source